IPO Update: Kaleido Biosciences Seeks $100 Million IPO [Seeking Alpha]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Seeking Alpha
IPO Update: Kaleido Biosciences Seeks $100 Million IPO Quick Take Kaleido Biosciences ( OTC:KLDO registration statement The company is developing microbiome-centric treatment candidates for hyperammonemia and other urea cycle disorders. KLDO is seeking a high valuation for a very early stage firm with no existing investor support for the IPO. Company & Technology Lexington, MA-based Kaleido was founded in 2015 to develop therapeutic agents utilizing the body’s microbiome. Management is headed by CEO Alison Lawton, who has been with the firm since December 2017 and was previously COO at Aura Biosciences. Below is a brief overview video of the human microbiome: Source: Kaleido is creating Microbiome Metabolic Therapies, MMTs, that ‘are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes.’ Below is the current status of the company’s drug development pipeline: Source: Company registration statem
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- General Mills explores selling $2B North America yogurt business - Reuters [Seeking Alpha]Seeking Alpha
- Exclusive-General Mills explores sale of $2 billion-plus yogurt business in North America, sources say [Yahoo! Finance]Yahoo! Finance
- Exclusive: General Mills explores sale of $2 billion-plus yogurt business in North America, sources say [Reuters]Reuters
- JPMorgan CEO Jamie Dimon hopes for soft landing for U.S. economy but says stagflation is possible [MSNBC.com]MSNBC.com
- I'm Set to Make a Massive Sum of Money. My Husband Is Aghast at My Plans for It. [Yahoo! Finance]Yahoo! Finance
JPM
Earnings
- 4/12/24 - Beat
JPM
Sec Filings
- 4/26/24 - Form 424B2
- 4/26/24 - Form 424B2
- 4/26/24 - Form 424B2
- JPM's page on the SEC website